A carregar...

Phase II study of dasatinib in the treatment of head and neck squamous cell carcinoma (HNSCC)

PURPOSE: Treatment options for patients with advanced HNSCC are scarce. This phase II study was conducted to evaluate the safety, tolerability, PK, and efficacy of dasatinib in this setting. EXPERIMENTAL DESIGN: Patients with recurrent and/or metastatic HNSCC after platinum-based therapy were treate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Brooks, Heather D., Glisson, Bonnie S., Bekele, B. Nebiyou, Ginsberg, Lawrence E., El-Naggar, Adel, Culotta, Kirk S., Takebe, Naoko, Wright, John, Tran, Hai T., Papadimitrakopoulou, Vassiliki A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117018/
https://ncbi.nlm.nih.gov/pubmed/21523723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25769
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!